- Home
- CRIS vs MDCX Comparison
CRIS vs MDCX Comparison
Compare CRIS & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.09
Company Overview
Basic Information| Metric | CRIS | MDCX |
|---|---|---|
| Founded | 2000 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.6M | 53.4M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRIS | MDCX |
|---|---|---|
| Price | $1.09 | $1.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $16.50 | ★ $23.50 |
| AVG Volume (30 Days) | 111.0K | ★ 346.6K |
| Earning Date | 11-06-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,650,000.00 | N/A |
| Revenue This Year | $6.13 | N/A |
| Revenue Next Year | $8.44 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.56 | N/A |
| 52 Week Low | $1.02 | $1.60 |
| 52 Week High | $4.50 | $8.94 |
Technical Indicators
Market Signals| Indicator | CRIS | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 35.77 | 36.34 |
| Support Level | $1.14 | $1.68 |
| Resistance Level | $1.41 | $2.03 |
| Average True Range (ATR) | 0.10 | 0.20 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 0.03 | 11.75 |
Price Performance
Historical Comparison CRIS
MDCX
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.